CDH1 and ovarian carcinoma: Conversely, in epithelial ovarian cancer (EOC) cells E-cadherin shows a high level of expression during tumor progression [3–6] being often expressed together with N-cadherin whose role in modulating signalling activation in these tumors is still unclear besides its association to chemoresistance [7].